compounding glp-1 news Compounding: When Innovation May Mean Liability FDA is moving to restrict
Description
SaveHealth reports that Zepbound and Wegovy, both FDA-approved weight loss injectables, differ in mechanisms and efficacy
Patients must remain vigilant
With the news that consumer food spending is in decline, attributed to Ozempic, we dive into the impact of GLP-1 on the food industry.
Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.
Get useful tips to avoid gaining weight after stopping Ozempic.
The CareCredit pharmacy network has nationwide locations making it easier to pay for prescriptions and other health-related products and services.
